The mechanism of alkylation of DNA by 5-(3-methyl-l-triazeno) imidazole-4-carboxamide (MIC), a metabolite of dic (NSC-45388) non-involvement of diazomethane
References (34)
- et al.
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—a new antitumor agent with activity against malignant melanoma
European J. Cancer
(1972) - et al.
Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man
Biochem. Pharmacol.
(1970) - et al.
Mechanism of action of 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide in mammalian cells in culture
Biochem. Pharmacol.
(1972) - et al.
Mechanism of carcinogenesis with 1-aryl-3,3-dialkyl-triazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro
Biochem. Pharmacol.
(1969) - et al.
Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide
Tox. Appl. Pharmacol.
(1971) - et al.
Methylation of DNA by 3H-14C-methyllabeled N-methyl-N- nitrosourea—evidence for transfer of the intact methyl group
Chem.-Biol. Interactions
(1973) - et al.
Carcinogenic nitroso compounds
Advan. Cancer Res.
(1967) - et al.
The mode of action of N-methyl-N′-nitro-N-nitrosoguanidine in mutagenesis. VII. The transfer of the methyl group of N-methyl-N′-nitro-N-nitrosoguanidine
Biochim. Biophys. Acta
(1972) - et al.
Imidazoles. II. 5(or 4)-monosubstituted triazenoimidazole-4-(or 5)-carboxamides
J. Med, Chem.
(1966) - et al.
Antitumor activity of triazenoimidazoles
Biochem. Pharmacol.
(1963)
Further investigation on the carcinostatic activity of 4(or 5)-aminoimidazole-5(or 4)-carboxamide derivatives: structure-activity relationship
Gann
(1968)
Antitumor activity of 4(or 5)-aminoimidazole-5(or 4)-carboxamide derivatives
Gann
(1965)
Carcinogenicity and possible mode of action of 4(5)-(3,3-dimethyl-l-triazeno)imidazole-5(4)-carboxamide (NSC-45388, DIC)
Carcinogenicity of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide (NSC-45388, DIC) and related chemicals in rats
Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent
J. Pharmacol Exp. Ther.
(1971)
n-Demethylation of the antineoplastic agent 4(5)-(3,3-dimethyl-1-triazeno)imidazoIe-5(4)-carboxamide by rats and man
Cancer Res.
(1970)
Metabolism of 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue
Cancer Chemother. Rep.
(1972)
Cited by (16)
Cancer Chemotherapy
2012, Withrow and MacEwen's Small Animal Clinical Oncology: Fifth EditionMechanism of the antileukemic effects of 1-p-carboxamidophenyl3,3-dimethyltriazene and its in vitro metabolites
1982, Biochemical PharmacologyAnalogs of pyrimidine and purine mononucleotide precursors as metabolic inhibitors
1981, Pharmacology and TherapeuticsGuanosine-methyldiazonium ion reaction. Variation of methylation product patterns with reaction variables
1977, BBA Section Nucleic Acids And Protein SynthesisTowards selectivity? Approaches to the design of new anti-tumour agents-II
1977, Cancer Treatment ReviewsAlteration of DNA by 5-(3-methyl-1- triazeno)imidazole-4-carboxamide (NSC-407347)
1976, Biochemical Pharmacology
Copyright © 1974 Published by Elsevier Ireland Ltd.